ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 425,44
0,02%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Cybin Inc (CYBN)

  7. Cybin Inc (CYBN) Actualités

CYBN

Cybin (CYBN)

Cybin Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:CYBN
DateHeureSourceTitreSymboleSociété
27/02/202419h34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]AMEX:CYBNCybin Inc
15/02/202417h09Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]AMEX:CYBNCybin Inc
04/01/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:CYBNCybin Inc
29/12/202323h15Edgar (US Regulatory)Form F-X - Appointment of Agent for Service of Process and UndertakingAMEX:CYBNCybin Inc
29/12/202323h09Edgar (US Regulatory)Form F-10 - Registration Statement for Securities of certain Canadian Issuers.AMEX:CYBNCybin Inc
29/11/202318h42Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:CYBNCybin Inc
17/11/202318h02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:CYBNCybin Inc
13/11/202312h06Edgar (US Regulatory)Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]AMEX:CYBNCybin Inc
07/11/202317h12Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:CYBNCybin Inc
17/08/202322h16Edgar (US Regulatory)Form F-10/A - Registration Statement for Securities of certain Canadian Issuers.: [Amend]AMEX:CYBNCybin Inc
28/06/202317h19Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)AMEX:CYBNCybin Inc
27/06/202323h13Edgar (US Regulatory)Annual Report (foreign Private Issuer) (40-f)AMEX:CYBNCybin Inc
16/06/202320h59Edgar (US Regulatory)Appointment of Agent for Service of Process and Undertaking (f-x)AMEX:CYBNCybin Inc
16/06/202320h15Edgar (US Regulatory)Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10)AMEX:CYBNCybin Inc
31/05/202312h01Edgar (US Regulatory)Voluntary Supplemental Material Filed Pursuant to Section 11(a) of the Securities Act of 1933 by Foreign Issuers (suppl)AMEX:CYBNCybin Inc
16/08/202212h25TipRanksCybin (CYBN) Receives a Buy from H.C. WainwrightAMEX:CYBNCybin Inc
08/08/202223h17Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)AMEX:CYBNCybin Inc
22/07/202222h35Edgar (US Regulatory)Amended Annual Report (foreign Private Issuer) (40-f/a)AMEX:CYBNCybin Inc
28/04/202217h43Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:CYBNCybin Inc
24/03/202213h18InvestorsHub NewsWireCybin-Sponsored Feasibility Study Using Kernel Flow Technology Currently Recruiting ParticipantsAMEX:CYBNCybin Inc
16/03/202214h40InvestorsHub NewsWireCybin to Participate in the 2022 Maxim Group Virtual Growth Conference on March 28-30, 2022AMEX:CYBNCybin Inc
02/03/202214h45InvestorWirePsychedelic Therapies Offer Hope for Mental HealthAMEX:CYBNCybin Inc
18/02/202214h37InvestorsHub NewsWireCybin Announces Additional Adelia Milestone AchievementAMEX:CYBNCybin Inc
15/02/202214h29InvestorsHub NewsWireThe Chopra Foundation Announces Partnership with Cybin Inc. to Increase Education and Awareness of the Potential Use of Psychedelics in Supporting Well-Being and Mental HealthAMEX:CYBNCybin Inc
11/02/202222h40Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:CYBNCybin Inc
09/02/202214h36InvestorsHub NewsWireCybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004 (Deuterated DMT) for the Treatment of Anxiety DisordersAMEX:CYBNCybin Inc
27/01/202214h35InvestorsHub NewsWireCybin to Announce Third Quarter Financial Results and Business Update on February 10, 2022AMEX:CYBNCybin Inc
11/01/202216h08InvestorsHub NewsWireInstitutional Review Board Grants Approval for Cybin-Sponsored Feasibility Study Using Kernel Flow Technology to Measure Psychedelic Effects on the BrainAMEX:CYBNCybin Inc
22/12/202114h21InvestorsHub NewsWireCybin Provides 2021 Year End SummaryAMEX:CYBNCybin Inc
21/12/202114h57InvestorsHub NewsWireCybin to Participate in the 11th Annual LifeSci Partners Corporate Access Event and H.C. Wainwright Bioconnect ConferenceAMEX:CYBNCybin Inc
 Showing the most relevant articles for your search:AMEX:CYBN

Dernières Valeurs Consultées

EU
BNP
BNP Paribas
EU
BEL20
Bel 20
EU
RI
Pernod Ricard
EU
VK
Vallourec
EU
EN
Bouygues
EU
BN
Danone
EU
VIV
Vivendi
NYSE
DIS
Walt Disney
SPI
SP500
S&P 500
EU
GLE
Societe Generale
NASDAQ
GOOGL
Alphabet
NASDAQ
NVDA
NVIDIA
EU
DG
Vinci
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés